BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vakalopoulos C. The effect of deficient muscarinic signaling on commonly reported biochemical effects in schizophrenia and convergence with genetic susceptibility loci in explaining symptom dimensions of psychosis. Front Pharmacol 2014;5:277. [PMID: 25566074 DOI: 10.3389/fphar.2014.00277] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Tolaymat M, Sundel MH, Alizadeh M, Xie G, Raufman JP. Potential Role for Combined Subtype-Selective Targeting of M1 and M3 Muscarinic Receptors in Gastrointestinal and Liver Diseases. Front Pharmacol 2021;12:786105. [PMID: 34803723 DOI: 10.3389/fphar.2021.786105] [Reference Citation Analysis]
2 Vakalopoulos C. The Glutamate Model of Schizophrenia: It's All About Signal Muscarinic Connections. J Pharmacol Exp Ther 2017;360:288. [PMID: 28082513 DOI: 10.1124/jpet.116.238766] [Reference Citation Analysis]
3 Xie Z, Yang X, Deng X, Ma M, Shu K. A Genome-Wide Association Study and Complex Network Identify Four Core Hub Genes in Bipolar Disorder. Int J Mol Sci 2017;18:E2763. [PMID: 29257106 DOI: 10.3390/ijms18122763] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
4 Bakker G, Vingerhoets C, Bloemen OJN, Sahakian BJ, Booij J, Caan MWA, van Amelsvoort TAMJ. The muscarinic M1 receptor modulates associative learning and memory in psychotic disorders. Neuroimage Clin 2020;27:102278. [PMID: 32563036 DOI: 10.1016/j.nicl.2020.102278] [Reference Citation Analysis]